Wells Fargo & Company Nkarta, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Nkarta, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 23,448 shares of NKTX stock, worth $123,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,448

Previous 10,885 115.42%

Holding current value

$123,570

Previous $117,000 17.95%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.27 - $10.82 $66,207 - $135,931	12,563 Added 115.42%	23,448 $138,000
Q1 2024 May 10, 2024	BUY	$5.59 - $15.71 $7,663 - $21,538	1,371 Added 14.41%	10,885 $117,000
Q4 2023 Feb 09, 2024	BUY	$1.31 - $6.6 $2,331 - $11,748	1,780 Added 23.02%	9,514 $62,000
Q3 2023 Nov 13, 2023	SELL	$1.39 - $2.29 $14,196 - $23,387	-10,213 Reduced 56.91%	7,734 $10,000
Q2 2023 Aug 15, 2023	BUY	$2.19 - $5.17 $11,087 - $26,175	5,063 Added 39.3%	17,947 $39,000
Q1 2023 May 12, 2023	SELL	$3.37 - $6.3 $9,928 - $18,559	-2,946 Reduced 18.61%	12,884 $45,000
Q4 2022 Feb 13, 2023	SELL	$5.14 - $14.35 $69,513 - $194,069	-13,524 Reduced 46.07%	15,830 $94,000
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $161,988 - $242,784	13,202 Added 81.74%	29,354 $386,000
Q2 2022 Aug 12, 2022	BUY	$7.77 - $19.44 $100,248 - $250,814	12,902 Added 396.98%	16,152 $200,000
Q1 2022 May 16, 2022	SELL	$8.66 - $14.99 $26,768 - $46,334	-3,091 Reduced 48.75%	3,250 $37,000
Q4 2021 Feb 14, 2022	SELL	$12.79 - $26.88 $21,627 - $45,454	-1,691 Reduced 21.05%	6,341 $97,000
Q2 2021 Aug 16, 2021	BUY	$23.94 - $36.68 $52,835 - $80,952	2,207 Added 37.89%	8,032 $254,000
Q1 2021 May 13, 2021	SELL	$31.33 - $59.61 $286,732 - $545,550	-9,152 Reduced 61.11%	5,825 $192,000
Q4 2020 Feb 09, 2021	BUY	$27.03 - $75.62 $67,358 - $188,445	2,492 Added 19.96%	14,977 $921,000
Q3 2020 Nov 05, 2020	BUY	$23.52 - $47.9 $293,647 - $598,031	12,485 New	12,485 $376,000

Others Institutions Holding NKTX

# of Institutions

120

Shares Held

66.2M

Call Options Held

142K

Put Options Held

43.1K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $256M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Nkarta, Inc. Transaction History